PNC-27 5mg | 20-Vial Kit | Anticancer Peptide Kit
$430
PNC-27 5mg | 20-Vial Kit — p53-derived proapoptotic peptide — penetrates HDM-2-overexpressing cancer cell membranes to trigger membranolytic apoptosis selectively in tumour cells that overexpress HDM-2. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Prostamax 20mg | 10-Vial Kit | Prostate Tissue Peptide Bioregulator
$260
Prostamax 20mg | 10-Vial Kit | Khavinson peptide bioregulator for prostate tissue — prostatic epithelial gene expression, urogenital function, and prostate geroprotection research. ≥99% HPLC, Janoshik COA. Research use only.
Prostamax 20mg | 20-Vial Kit | Prostate Tissue Peptide Bioregulator
$470
Prostamax 20mg | 10-Vial Kit | Khavinson peptide bioregulator for prostate tissue — prostatic epithelial gene expression, urogenital function, and prostate geroprotection research. ≥99% HPLC, Janoshik COA. Research use only.
PT-141 10mg | 10-Vial Kit | Bremelanotide Kit
$210
PT-141 10mg | 10-Vial Kit — Bremelanotide MC3R/MC4R agonist — activates hypothalamic melanocortin receptors to drive central sexual arousal independently of vascular mechanisms; FDA-approved mechanism for HSDD research. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
PT-141 10mg | 20-Vial Kit | Bremelanotide Kit
$370
PT-141 10mg | 20-Vial Kit — Bremelanotide MC3R/MC4R agonist — activates hypothalamic melanocortin receptors to drive central sexual arousal independently of vascular mechanisms; FDA-approved mechanism for HSDD research. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
PTD-DBM 5mg | 10-Vial Kit | Wnt/CXXC5 Pathway Modulator
$320
PTD-DBM 5mg | 10-Vial Kit | Wnt pathway activator via CXXC5-Dishevelled interaction disruption — hair follicle regeneration and skin wound healing research. ≥99% HPLC, Janoshik COA. Research use only.
PTD-DBM 5mg | 20-Vial Kit | Wnt/CXXC5 Pathway Modulator
$590
PTD-DBM 5mg | 10-Vial Kit | Wnt pathway activator via CXXC5-Dishevelled interaction disruption — hair follicle regeneration and skin wound healing research. ≥99% HPLC, Janoshik COA. Research use only.
Retatrutide + Cagrilintide Blend 10mg | 10-Vial Kit | Triple/Dual Agonist Stack
$310
Retatrutide + Cagrilintide Blend 10mg | 10-Vial Kit — Long-acting amylin receptor agonist — reduces food intake via area postrema satiety signalling, slows gastric emptying, and suppresses postprandial glucagon independently of GLP-1 pathways. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide + Cagrilintide Blend 10mg | 20-Vial Kit | Triple/Dual Agonist Stack
$570
Retatrutide + Cagrilintide Blend 10mg | 20-Vial Kit — Long-acting amylin receptor agonist — reduces food intake via area postrema satiety signalling, slows gastric emptying, and suppresses postprandial glucagon independently of GLP-1 pathways. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 100mg | 10-Vial Kit | Triple GIP/GLP-1/Glucagon Agonist | Obesity & Metabolic Research
$750
Retatrutide (LY3437943 / triple incretin agonist, CAS 2381932-72-3) 100mg — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 100mg | 20-Vial Kit | Triple GIP/GLP-1/Glucagon Agonist | Obesity & Metabolic Research
$1,450
Retatrutide (LY3437943 / triple incretin agonist, CAS 2381932-72-3) 100mg — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 10mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
$230
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 10mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
$410
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 15mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
$280
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 15mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
$510
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 20mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
$300
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 20mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
$550
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 30mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
$330
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 30mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
$610
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 40mg | 10-Vial Kit | 400mg Total | Triple Agonist GIP/GLP-1/Glucagon
$420
Retatrutide 40mg — triple GLP-1R/GIPR/GCGR agonist, 24.2% Phase 2 weight loss. ≥99% HPLC, Janoshik COA. 10-vial kit. Research use only.
Retatrutide 40mg | 20-Vial Kit | 800mg Total | Triple Agonist GIP/GLP-1/Glucagon
$790
Retatrutide 40mg — triple GLP-1R/GIPR/GCGR agonist, 24.2% Phase 2 weight loss. ≥99% HPLC, Janoshik COA. 20-vial kit. Research use only.
Retatrutide 50mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
$470
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 50mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
$890
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 5mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
$190
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.